Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration has granted Emergency Use Authorization for a Zika assay from Luminex, the firm announced today.

The test, called the xMAP MultiFLEX Zika RNA Assay, was designed by Luminex partner GenArraytion, a Rockville, Maryland-based diagnostics maker. The xMAP test is authorized to detect viral RNA in blood or serum, as well as urine samples collected and tested in conjunction with blood or serum. It will be provided to labs that are CLIA certified to run highly complex tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.